Attorney General Charity Clark has announced that Vermont, along with 50 other states and territories, is seeking preliminary approval for a $39.1 million settlement with Apotex, a generic drug manufacturer. This legal action addresses allegations of conspiracy to inflate prices and limit competition in the market for certain generic drugs.
The settlement was initially announced last fall alongside a $10 million agreement with Heritage Pharmaceuticals. At that time, the settlement required signatures from all involved states and territories, which have now been obtained. The coalition is filing the settlement today in the U.S. District Court for the District of Connecticut located in Hartford.
Consumers who purchased specific generic prescription drugs between 2010 and 2018 may be eligible for compensation under this settlement. To verify eligibility, individuals can call 1-866-290-0182 (Toll-Free), email info@AGGenericDrugs.com or visit www.AGGenericDrugs.com.
The settlements aim to resolve claims that Apotex and Heritage engaged in widespread conspiracies to artificially increase drug prices, reduce competition, and restrain trade unreasonably concerning numerous generic medications. As part of their agreements, both companies have pledged to cooperate with ongoing multistate litigations involving 30 corporate defendants and 25 individual executives. Additionally, they have agreed to implement internal reforms designed to promote fair competition and adherence to antitrust laws.
"These settlements are an important step forward in holding these companies accountable," said Attorney General Charity Clark.